John A. Fry
John A. Fry's purchase track record
John A. Fry has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 11/28/2022 | VTVT | $51K | -6.6% | -3.4% | +6.1% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
VTVT Completes Phase 3 Cadisegliatin Trial Enrollment. vTv Therapeutics announced that enrollment for its phase 3 cadisegliatin trial in type 1 diabetes has been completed. The milestone moves the program closer to the next study stage and may influence future clinical and commercial outlook. The stock is currently trading near a long‑standing support level that has been tested many times.
Transaction History
| CYH | ▲ Buy | Option Exercise | 9,756 | $0 | 3/1/2026 | View on chart |
| CYH | ▲ Buy | Option Exercise | 20,906 | $0 | 3/1/2026 | View on chart |
| CYH | ▲ Buy | Option Exercise | 19,933 | $0 | 3/1/2026 | View on chart |
| CYH | ▲ Buy | Option Exercise | 5,894 | $0 | 3/1/2025 | View on chart |
| CYH | ▲ Buy | Option Exercise | 9,756 | $0 | 3/1/2025 | View on chart |
| CYH | ▲ Buy | Option Exercise | 20,906 | $0 | 3/1/2025 | View on chart |
| CYH | ▲ Buy | Option Exercise | 6,432 | $0 | 3/1/2024 | View on chart |
| CYH | ▲ Buy | Option Exercise | 5,894 | $0 | 3/1/2024 | View on chart |
| CYH | ▲ Buy | Option Exercise | 9,756 | $0 | 3/1/2024 | View on chart |
| CYH | ▲ Buy | Option Exercise | 5,894 | $0 | 3/1/2023 | View on chart |
| CYH | ▲ Buy | Option Exercise | 6,432 | $0 | 3/1/2023 | View on chart |
| CYH | ▲ Buy | Option Exercise | 11,494 | $0 | 3/1/2023 | View on chart |
| VTVT | ▲ Buy | Open Market | 40,461 | $34K | 11/29/2022 | View on chart |
| VTVT | ▲ Buy | Open Market | 20,539 | $17K | 11/28/2022 | View on chart |
| CYH | ▲ Buy | Option Exercise | 11,356 | $0 | 3/1/2022 | View on chart |
| CYH | ▲ Buy | Option Exercise | 11,495 | $0 | 3/1/2022 | View on chart |
| CYH | ▲ Buy | Option Exercise | 6,432 | $0 | 3/1/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 26, 2026
BMO Initiates CYH Coverage With Market Perform Rating
BMO Capital has started covering Community Health Systems with a Market Perform rating and a price target of $3. This follows broader sector discussions on elective demand and rising junk bond yields. The stock is currently trading near its support level, reflecting mixed sentiment among analysts.
BMO Initiates CYH Coverage With Market Perform Rating. BMO Capital has started covering Community Health Systems with a Market Perform rating and a price target of $3. This follows broader sector discussions on elective demand and rising junk bond yields. The stock is currently trading near its support level, reflecting mixed sentiment among analysts.